Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the <scp>SUSTAIN</scp> 1, 2, 5 and 9 trials: <i>Post‐hoc</i> analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

Published:2022-10-12 Issue:12 Volume:13 Page:1971-1980
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Araki Eiichi¹^ORCID,Harashima Shinichi²,Nishida Tomoyuki³,Nakamura Jiro⁴

Affiliation:

1. Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. Goshominami Harashima Clinic, Human Health Science Graduate School of Medicine Kyoto University Kyoto Japan

3. Novo Nordisk Pharma Ltd. Tokyo Japan

4. Aichi Medical University Nagakute Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13905

Reference19 articles.

1. Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

2. Type 2 diabetes via β-cell dysfunction in east Asian people

3. β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians

4. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

5. Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes;Diabetes Therapy;2024-01-18

2. Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease;Hypertension Research;2023-10-17

3. Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus;Diabetes, Obesity and Metabolism;2023-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3